Compound Overviews
What Is Tirzepatide? Dual GLP-1 / GIP Agonist Research Overview
Tirzepatide is a dual-receptor agonist — it activates both the GLP-1 and GIP receptors — and one of the most studied compounds in modern metabolic research. This overview is for laboratory and educational reference only.
What is tirzepatide?
Tirzepatide is a synthetic, long-acting peptide described in the literature as a dual agonist of the GLP-1 and GIP incretin receptors. It represents the "dual" step in the broader incretin progression: mono (semaglutide, GLP-1) → dual (tirzepatide, GLP-1/GIP) → triple (retatrutide, GLP-1/GIP/glucagon).
Mechanism: two receptors
GLP-1: the base arm
The GLP-1 arm is the best-characterized mechanism of the class — studied for satiety signaling in the central nervous system, slowed gastric emptying, and glucose-dependent insulin secretion.
GIP: the potentiator
The GIP arm is what distinguishes tirzepatide from a GLP-1-only agonist. Research studies GIP as a potentiator of insulin response, a modulator of adipose-tissue lipid handling, and — combined with GLP-1 — a possible contributor to better tolerability.
Clinical evidence
Obesity — the SURMOUNT program
The SURMOUNT-1 obesity trial (Jastreboff et al., New England Journal of Medicine, 2022) reported substantial mean weight reductions over 72 weeks, establishing tirzepatide as a benchmark dual agonist in body-weight research.1
Type 2 diabetes — the SURPASS program
The SURPASS trials studied tirzepatide for glycemic control in type 2 diabetes, reporting significant HbA1c reductions across the program.2
Tirzepatide vs Semaglutide vs Retatrutide
| Compound | Receptors | Research status |
|---|---|---|
| Semaglutide | GLP-1 (mono) | Approved formulations exist |
| Tirzepatide | GLP-1 + GIP (dual) | Approved formulations exist |
| Retatrutide | GLP-1 + GIP + glucagon (triple) | Phase 3 (investigational) |
For the triple-agonist comparison in depth, see What Is Retatrutide (GLP-3)?, the class fundamentals in GLP-1 Agonists: How Incretin Analogs Work, and the full category map in Peptides for Fat Loss.
Handling and reconstitution
Tirzepatide ships as a lyophilized powder, reconstituted with bacteriostatic water for laboratory use and refrigerated (2–8°C) afterward. See Understanding Peptide Reconstitution and How to Store Research Peptides.
Verified purity
Renova material is synthesized and lyophilized in the USA and ships with a per-batch third-party COA (HPLC purity, mass-spec identity, test date). Confirm any lot with Verify Your Vial and read How to Read a Peptide COA.
References
Questions
Frequently Asked
What is tirzepatide?
Tirzepatide is a synthetic peptide described in the research literature as a dual-receptor agonist that activates both the GLP-1 and GIP receptors. It is one of the most studied compounds in metabolic and body-weight research.
How is tirzepatide different from semaglutide and retatrutide?
By how many incretin receptors it activates. Semaglutide is a single GLP-1 agonist, tirzepatide is a dual GLP-1/GIP agonist, and retatrutide is a triple GLP-1/GIP/glucagon agonist. Tirzepatide sits in the middle of the mono-to-triple progression.
What does GIP add on top of GLP-1?
In the research literature, the GIP arm is studied as a potentiator of insulin response and a modulator of adipose-tissue handling, and is also discussed for attenuating nausea, which may improve tolerability relative to a GLP-1-only agonist.
How is tirzepatide supplied and stored?
As a lyophilized (freeze-dried) powder reconstituted with bacteriostatic water for laboratory use and refrigerated (2–8°C) after reconstitution. Renova material ships with a per-batch third-party COA.
Related Compounds
Shop the Research
Keep Reading
Related Research
For Research Use Only · Not For Human Consumption · Renova Wellness™